| Type | MGI:General | Description | increases survival of fully MHC-mismatched cardiac allografts (12 +/- 5 days) compared to wild-type (8 +/- 1 days) treatment with rapamycin significantly prolongs allograft survival (53 +/- 12 days) compared to treated wild-type (11 +/- 2 days) |
